MTOR and endometrial cancer: Moreover, they are also able to induce the activation of the phosphatidylinositol 3-kinase-Akt-mammalian target of the rapamycin (PI3K/AKT/mTOR) pathway signaling involved in endometrial cancer (EC) proliferation and progression [19,20].